ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023
Ultrasound-Driven On-Demand Transient Triboelectric Nanogenerator for Subcutaneous Antibacterial Activity.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Emerging Triboelectric Nanogenerators for In-Body Implantation.Small methods · 2026Review
- Enhancing Ultrasound Power Transfer: Efficiency, Acoustics, and Future Directions.Advanced materials (Deerfield Beach, Fla.) · 2025Review
- Advances in Electrical Materials for Bone and Cartilage Regeneration: Developments, Challenges, and Perspectives.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Review
- A Body Conformal Ultrasound Receiver for Efficient and Stable Wireless Power Transfer in Deep Percutaneous Charging.Advanced materials (Deerfield Beach, Fla.) · 2025Article
- Advances in Triboelectric Nanogenerators for Microbial Disinfection.Micromachines · 2025Review
- High-frequency ultrasound modulation of ZnUltrasonics sonochemistry · 2024Article
- Advanced Ultrasound Energy Transfer Technologies using Metamaterial Structures.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024Review
- Bulk Schottky Junctions-Based Flexible Triboelectric Nanogenerators to Power Backscatter Communications in Green 6G Networks.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024Article
- From Body Monitoring to Biomolecular Sensing: Current Progress and Future Perspectives of Triboelectric Nanogenerators in Point-of-Care Diagnostics.Sensors (Basel, Switzerland) · 2024Review
- Advances in Bioresorbable Triboelectric Nanogenerators.Chemical reviews · 2023Review
- Sandwich-type double-layer piezoelectric nanogenerators based on one- and two-dimensional ZnO nanostructures with improved output performance.Scientific reports · 2023Article
- Transparent Electronics for Wearable Electronics Application.Chemical reviews · 2023Review
- Ultrasound-Driven On-Demand Transient Triboelectric Nanogenerator for Subcutaneous Antibacterial Activity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
To prevent surgical site infection (SSI), which significantly increases the rate morbidity and mortality, eliminating microorganisms is prominent. Antimicrobial resistance is identified as a global health challenge. This work proposes a new strategy to eliminate microorganisms of deep tissue through electrical stimulation with an ultrasound (US)-driven implantable, biodegradable, and vibrant triboelectric nanogenerator (IBV-TENG). After a programmed lifetime, the IBV-TENG can be eliminated by provoking the on-demand device dissolution by controlling US intensity with no surgical removal of the device from the body. A voltage of ≈4 V and current of ≈22 µA generated from IBV-TENG under ultrasound in vitro, confirming inactivating ≈100% of Staphylococcus aureus and ≈99% of Escherichia coli. Furthermore, ex vivo results show that IBV-TENG implanted under porcine tissue successfully inactivates bacteria. This antibacterial technology is expected to be a countermeasure strategy against SSIs, increasing life expectancy and healthcare quality by preventing microorganisms of deep tissue.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.